Qed Therapeutics
Qed Therapeutics is a small Molecule Targeting Tyrosine Kinase Receptors founded in 2018.
Overview
Qed Therapeutics is a small Molecule Targeting Tyrosine Kinase Receptors founded in 2018.
-
Website:
- Social accounts:
Industries
Qed Therapeutics is active in the following industries: